[Tanvex-KY] Announcement of the board's resolution to convene the 2026 Annual Shareholders' Meeting (with added agenda items)
NQ Score
0/100
N1 Content Completeness
5
AI Summary (NQ-processed)
Tanvex BioPharma's board resolved to hold its AGM on June 4, 2026. Key agenda items include a deficit compensation plan and a private placement for capital injection.